Download PDF
Semin Respir Crit Care Med 2010; 31(2): 123-138
DOI: 10.1055/s-0030-1249109
© Thieme Medical Publishers

Lung Transplantation for Advanced Bronchiectasis

Don Hayes1 , Keith C. Meyer2
  • 1Departments of Pediatrics, Internal Medicine, and Surgery, University of Kentucky College of Medicine, Lexington, Kentucky
  • 2Section of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Further Information

Publication History

Publication Date:
30 March 2010 (online)

    Permissions and Reprints

ABSTRACT

Lung transplant (LT) can be successfully performed on patients with advanced bronchiectatic lung disease with subsequent good posttransplant quality of life and long-term outcome. Most of the data are derived from patients with cystic fibrosis (CF), but LT can be effective in patients with non-CF bronchiectasis as well. Despite the presence of chronic lower respiratory tract infection with bacterial pathogens in these patients pretransplant, posttransplant infections do not generally have significant impact on survival, although infection with antibiotic-resistant bacteria may complicate posttransplant management. Although benefit of LT for young children with CF is somewhat controversial, LT can clearly benefit older children and adults with advanced lung disease due to bronchiectasis. This article reviews indications (and contraindications) for LT, discusses particular problems that may arise posttransplant, and provides a rationale for referring patients with bronchiectasis for LT.

KEYWORDS

Cystic fibrosis - bronchiectasis - lung transplantation

REFERENCES

  • 1 Barker A F. Bronchiectasis.  N Engl J Med. 2002;  346 1383-1393
    CrossrefPubMedGoogle Scholar
  • 2 O'Donnell A E. Bronchiectasis.  Chest. 2008;  134 815-823
    CrossrefPubMedGoogle Scholar
  • 3 Loebinger M R, Wells A U, Hansell D M et al.. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival.  Eur Respir J. 2009;  34 843-849
    CrossrefPubMedGoogle Scholar
  • 4 Courtney J M, Kelly M G, Watt A et al.. Quality of life and inflammation in exacerbations of bronchiectasis.  Chron Respir Dis. 2008;  5 161-168
    CrossrefPubMedGoogle Scholar
  • 5 Feltrim M I, Rozanski A, Borges A C, Cardoso C A, Caramori M L, Pego-Fernandes P. The quality of life of patients on the lung transplantation waiting list.  Transplant Proc. 2008;  40 819-821
    CrossrefPubMedGoogle Scholar
  • 6 Kerem B, Rommens J M, Buchanan J A et al.. Identification of the cystic fibrosis gene: genetic analysis.  Science. 1989;  245 1073-1080
    CrossrefPubMedGoogle Scholar
  • 7 Mueller C, Flotte T R. Gene therapy for cystic fibrosis.  Clin Rev Allergy Immunol. 2008;  35 164-178
    PubMedGoogle Scholar
  • 8 Ratjen F, Döring G. Cystic fibrosis.  Lancet. 2003;  361 681-689
    CrossrefPubMedGoogle Scholar
  • 9 Tunney M M, Field T R, Moriarty T F et al.. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.  Am J Respir Crit Care Med. 2008;  177 995-1001
    CrossrefPubMedGoogle Scholar
  • 10 Worlitzsch D, Tarran R, Ulrich M et al.. Reduced oxygen concentrations in airway mucus contribute to the early and late pathogenesis of Pseudomonas aeruginosa cystic fibrosis airways infection.  J Clin Invest. 2002;  109 317-325
    CrossrefPubMedGoogle Scholar
  • 11 Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection.  J Cyst Fibros. 2005;  4(Suppl 2) 49-54
    PubMedGoogle Scholar
  • 12 Christie J D, Edwards L B, Aurora P et al.. The registry of the International Society for Heart and Lung Transplantation: Twenty-Sixth Official Adult Lung and Heart–Lung Transplantation Report–2009.  J Heart Lung Transplant. 2009;  28 1031-1049
    CrossrefPubMedGoogle Scholar
  • 13 Orens J B, Estenne M, Arcasoy S Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.  J Heart Lung Transplant. 2006;  25 745-755
    CrossrefPubMedGoogle Scholar
  • 14 Bartz R R, Love R B, Leverson G E, Will L R, Welter D L, Meyer K C. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis.  J Heart Lung Transplant. 2003;  22 433-438
    CrossrefPubMedGoogle Scholar
  • 15 Kerem E, Reisman J, Corey M, Canny G J, Levison H. Prediction of mortality in patients with cystic fibrosis.  N Engl J Med. 1992;  326 1187-1191
    CrossrefPubMedGoogle Scholar
  • 16 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  J Heart Lung Transplant. 1998;  17 703-709
    PubMedGoogle Scholar
  • 17 Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss C H, Aitken M L. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.  Am J Respir Crit Care Med. 2002;  166(12 Pt 1) 1550-1555
    CrossrefPubMedGoogle Scholar
  • 18 Rosenbluth D B, Wilson K, Ferkol T, Schuster D P. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.  Chest. 2004;  126 412-419
    CrossrefPubMedGoogle Scholar
  • 19 Ellaffi M, Vinsonneau C, Coste J et al.. One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.  Am J Respir Crit Care Med. 2005;  171 158-164
    CrossrefPubMedGoogle Scholar
  • 20 Milla C E, Warwick W J. Risk of death in cystic fibrosis patients with severely compromised lung function.  Chest. 1998;  113 1230-1234
    CrossrefPubMedGoogle Scholar
  • 21 Doershuk C F, Stern R C. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival.  Chest. 1999;  115 782-787
    CrossrefPubMedGoogle Scholar
  • 22 Augarten A, Akons H, Aviram M et al.. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients.  Pediatr Transplant. 2001;  5 339-342
    CrossrefPubMedGoogle Scholar
  • 23 Belkin R A, Henig N R, Singer L G et al.. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.  Am J Respir Crit Care Med. 2006;  173 659-666
    CrossrefPubMedGoogle Scholar
  • 24 Snell G I, Bennetts K, Bartolo J et al.. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation.  J Heart Lung Transplant. 1998;  17 1097-1103
    PubMedGoogle Scholar
  • 25 Stanchina M L, Tantisira K G, Aquino S L, Wain J C, Ginns L C. Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation.  J Heart Lung Transplant. 2002;  21 217-225
    CrossrefPubMedGoogle Scholar
  • 26 Tantisira K G, Systrom D M, Ginns L C. An elevated breathing reserve index at the lactate threshold is a predictor of mortality in patients with cystic fibrosis awaiting lung transplantation.  Am J Respir Crit Care Med. 2002;  165 1629-1633
    CrossrefPubMedGoogle Scholar
  • 27 Liou T G, Adler F R, Cahill B C et al.. Survival effect of lung transplantation among patients with cystic fibrosis.  JAMA. 2001;  286 2683-2689
    CrossrefPubMedGoogle Scholar
  • 28 Liou T G, Adler F R, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis.  Am J Respir Crit Care Med. 2005;  171 1053-1059
    CrossrefPubMedGoogle Scholar
  • 29 Liou T G, Adler F R, Cox D R, Cahill B C. Lung transplantation and survival in children with cystic fibrosis.  N Engl J Med. 2007;  357 2143-2152
    CrossrefPubMedGoogle Scholar
  • 30 Egan T M. Solid benefit of lung transplantation for some children with cystic fibrosis.  Pediatr Transplant. 2008;  12 125-128
    CrossrefPubMedGoogle Scholar
  • 31 Sweet S C, Aurora P, Benden C International Pediatric Lung Transplant Collaborative et al. Lung transplantation and survival in children with cystic fibrosis: solid statistics—flawed interpretation.  Pediatr Transplant. 2008;  12 129-136
    CrossrefPubMedGoogle Scholar
  • 32 Aurora P, Carby M, Sweet S. Selection of cystic fibrosis patients for lung transplantation.  Curr Opin Pulm Med. 2008;  14 589-594
    CrossrefPubMedGoogle Scholar
  • 33 Ziedalski T M, Kao P N, Henig N R, Jacobs S S, Ruoss S J. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.  Chest. 2006;  130 995-1002
    CrossrefPubMedGoogle Scholar
  • 34 Hasan A, Corris P A, Healy M et al.. Bilateral sequential lung transplantation for end stage septic lung disease.  Thorax. 1995;  50 565-566
    CrossrefPubMedGoogle Scholar
  • 35 Arcasoy S M, Kotloff R M. Lung transplantation.  N Engl J Med. 1999;  340 1081-1091
    CrossrefPubMedGoogle Scholar
  • 36 Barlow C W, Robbins R C, Moon M R, Akindipe O, Theodore J, Reitz B A. Heart-lung versus double-lung transplantation for suppurative lung disease.  J Thorac Cardiovasc Surg. 2000;  119 466-476
    CrossrefPubMedGoogle Scholar
  • 37 Rao J N, Forty J, Hasan A et al.. Bilateral lung transplant: the procedure of choice for end-stage septic lung disease.  Transplant Proc. 2001;  33 1622-1623
    CrossrefPubMedGoogle Scholar
  • 38 Beirne P A, Banner N R, Khaghani A, Hodson M E, Yacoub M H. Lung transplantation for non-cystic fibrosis bronchiectasis: analysis of a 13-year experience.  J Heart Lung Transplant. 2005;  24 1530-1535
    CrossrefPubMedGoogle Scholar
  • 39 Ikegami T, Sanchez E Q, Uemura T et al.. Liver transplantation for cystic fibrosis in adults.  Surg Today. 2008;  38 26-29
    CrossrefPubMedGoogle Scholar
  • 40 Fridell J A, Bond G J, Mazariegos G V et al.. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.  J Pediatr Surg. 2003;  38 1152-1156
    CrossrefPubMedGoogle Scholar
  • 41 Milkiewicz P, Skiba G, Kelly D et al.. Transplantation for cystic fibrosis: outcome following early liver transplantation.  J Gastroenterol Hepatol. 2002;  17 208-213
    CrossrefPubMedGoogle Scholar
  • 42 Forty J, Hasan A, Gould F K, Corris P A, Dark J H. Single lung transplantation with simultaneous contralateral pneumonectomy for cystic fibrosis.  J Heart Lung Transplant. 1994;  13 727-730
    PubMedGoogle Scholar
  • 43 Souilamas R, Mostafa A, Guillemain R, Boussaud V, Amrein C, Chevalier P. Single-lung transplantation for cystic fibrosis and metachronus pneumonectomy: case reports.  Transplant Proc. 2008;  40 3594-3595
    CrossrefPubMedGoogle Scholar
  • 44 Wilson C B, Jones P W, O'Leary C J, Hansell D M, Cole P J, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.  Eur Respir J. 1997;  10 1754-1760
    CrossrefPubMedGoogle Scholar
  • 45 Martínez-García M A, Soler-Cataluña J J, Perpiñá-Tordera M, Román-Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.  Chest. 2007;  132 1565-1572
    CrossrefPubMedGoogle Scholar
  • 46 Aris R M, Gilligan P H, Neuringer I P, Gott K K, Rea J, Yankaskas J R. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.  Am J Respir Crit Care Med. 1997;  155 1699-1704
    PubMedGoogle Scholar
  • 47 Hadjiliadis D, Steele M P, Chaparro C et al.. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.  J Heart Lung Transplant. 2007;  26 834-838
    CrossrefPubMedGoogle Scholar
  • 48 De Soyza A, Archer L, Wardle J et al.. Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis.  J Heart Lung Transplant. 2003;  22 764-769
    CrossrefPubMedGoogle Scholar
  • 49 Dobbin C, Maley M, Harkness J et al.. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.  J Hosp Infect. 2004;  56 277-282
    CrossrefPubMedGoogle Scholar
  • 50 Helmi M, Love R B, Welter D, Cornwell R D, Meyer K C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.  Chest. 2003;  123 800-808
    CrossrefPubMedGoogle Scholar
  • 51 Nunley D R, Ohori P, Grgurich W F et al.. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients.  Chest. 1998;  114 1321-1329
    CrossrefPubMedGoogle Scholar
  • 52 Cimon B, Carrère J, Vinatier J F, Chazalette J P, Chabasse D, Bouchara J P. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis.  Eur J Clin Microbiol Infect Dis. 2000;  19 53-56
    CrossrefPubMedGoogle Scholar
  • 53 Symoens F, Knoop C, Schrooyen M et al.. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.  J Heart Lung Transplant. 2006;  25 603-607
    CrossrefPubMedGoogle Scholar
  • 54 Chernenko S M, Humar A, Hutcheon M et al.. Mycobacterium abscessus infections in lung transplant recipients: the international experience.  J Heart Lung Transplant. 2006;  25 1447-1455
    CrossrefPubMedGoogle Scholar
  • 55 Chalermskulrat W, Sood N, Neuringer I P et al.. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.  Thorax. 2006;  61 507-513
    CrossrefPubMedGoogle Scholar
  • 56 Aris R M, Routh J C, LiPuma J J, Heath D G, Gilligan P H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.  Am J Respir Crit Care Med. 2001;  164 2102-2106
    CrossrefPubMedGoogle Scholar
  • 57 Liou T G, Adler F R, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis.  Am J Respir Crit Care Med. 2005;  171 1053-1059
    CrossrefPubMedGoogle Scholar
  • 58 Alexander B D, Petzold E W, Reller L B et al.. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex.  Am J Transplant. 2008;  8 1025-1030
    CrossrefPubMedGoogle Scholar
  • 59 Murray S, Charbeneau J, Marshall B C, LiPuma J J. Impact of Burkholderia infection on lung transplantation in cystic fibrosis.  Am J Respir Crit Care Med. 2008;  178 363-371
    CrossrefPubMedGoogle Scholar
  • 60 Snell G I, Levvey B J, Oto T et al.. Early lung transplantation success utilizing controlled donation after cardiac death donors.  Am J Transplant. 2008;  8 1282-1289
    CrossrefPubMedGoogle Scholar
  • 61 Cypel M, Sato M, Yildirim E et al.. Initial experience with lung donation after cardiocirculatory death in Canada.  J Heart Lung Transplant. 2009;  28 753-758
    CrossrefPubMedGoogle Scholar
  • 62 Starnes V A, Bowdish M E, Woo M S et al.. A decade of living lobar lung transplantation: recipient outcomes.  J Thorac Cardiovasc Surg. 2004;  127 114-122
    CrossrefPubMedGoogle Scholar
  • 63 Rosbe K W, Jones D T, Rahbar R, Lahiri T, Auerbach A D. Endoscopic sinus surgery in cystic fibrosis: do patients benefit from surgery?.  Int J Pediatr Otorhinolaryngol. 2001;  61 113-119
    CrossrefPubMedGoogle Scholar
  • 64 Holzmann D, Speich R, Kaufmann T et al.. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience.  Transplantation. 2004;  77 134-136
    CrossrefPubMedGoogle Scholar
  • 65 Leung M K, Rachakonda L, Weill D et al.. Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis.  Am J Rhinol. 2008;  22 192-196
    CrossrefPubMedGoogle Scholar
  • 66 Schwebel C, Pin I, Barnoud D et al.. Prevalence and consequences of nutritional depletion in lung transplant candidates.  Eur Respir J. 2000;  16 1050-1055
    CrossrefPubMedGoogle Scholar
  • 67 Mozzillo E, Franzese A, Valerio G et al.. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.  Pediatr Diabetes. 2009;  10 162-167
    CrossrefPubMedGoogle Scholar
  • 68 Stringer D A, Sprigg A, Juodis E et al.. The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function.  Can Assoc Radiol J. 1988;  39 100-102
    PubMedGoogle Scholar
  • 69 Brodzicki J, Trawińska-Bartnicka M, Korzon M. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.  Med Sci Monit. 2002;  8 CR529-CR537
    PubMedGoogle Scholar
  • 70 Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott M J. High prevalence of gastroesophageal reflux in children after lung transplantation.  Pediatr Pulmonol. 2005;  40 68-71
    CrossrefPubMedGoogle Scholar
  • 71 Blondeau K, Mertens V, Vanaudenaerde B A et al.. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection.  Eur Respir J. 2008;  31 707-713
    CrossrefPubMedGoogle Scholar
  • 72 Palmer S M, Miralles A P, Howell D N, Brazer S R, Tapson V F, Davis R D. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation.  Chest. 2000;  118 1214-1217
    CrossrefPubMedGoogle Scholar
  • 73 D'Ovidio F, Mura M, Ridsdale R et al.. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D.  Am J Transplant. 2006;  6 1930-1938
    CrossrefPubMedGoogle Scholar
  • 74 Dellon E S, Morgan D R, Mohanty S P, Davis K, Aris R M. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation.  Transplantation. 2006;  81 1141-1146
    CrossrefPubMedGoogle Scholar
  • 75 Morton J R, Ansari N, Glanville A R, Meagher A P, Lord R V. Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation.  J Gastrointest Surg. 2009;  13 1448-1453
    CrossrefPubMedGoogle Scholar
  • 76 Yates B, Murphy D M, Fisher A J et al.. Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.  Thorax. 2007;  62 554-556
    CrossrefPubMedGoogle Scholar
  • 77 Bhardwaj S, Canlas K, Kahi C et al.. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.  J Clin Gastroenterol. 2009;  , Jun 11. [Epub ahead of print]
    PubMedGoogle Scholar
  • 78 Nash K L, Allison M E, McKeon D et al.. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.  J Cyst Fibros. 2008;  7 252-257
    CrossrefPubMedGoogle Scholar
  • 79 Klima L D, Kowdley K V, Lewis S L, Wood D E, Aitken M L. Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series.  J Heart Lung Transplant. 1997;  16 934-938
    PubMedGoogle Scholar
  • 80 King S J, Topliss D J, Kotsimbos T et al.. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.  Eur Respir J. 2005;  25 54-61
    CrossrefPubMedGoogle Scholar
  • 81 Quattrucci S, Rolla M, Cimino G et al.. Lung transplantation for cystic fibrosis: 6-year follow-up.  J Cyst Fibros. 2005;  4 107-114
    CrossrefPubMedGoogle Scholar
  • 82 Spahr J E, Love R B, Francois M, Radford K, Meyer K C. Lung transplantation for cystic fibrosis: current concepts and one center's experience.  J Cyst Fibros. 2007;  6 334-350
    CrossrefPubMedGoogle Scholar
  • 83 Meyer K C. The Role of Neutrophils in Transplantation: Immunobiology of Organ Transplantation. New York; Kluwer/Plenum 2004: 493-507
    Google Scholar
  • 84 Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.  Eur J Cardiothorac Surg. 2007;  32 35-41
    CrossrefPubMedGoogle Scholar
  • 85 Dupuis R E, Sredzienski E S. Tobramycin pharmacokinetics in patients with cystic fibrosis preceding and following lung transplantation.  Ther Drug Monit. 1999;  21 161-165
    CrossrefPubMedGoogle Scholar
  • 86 Saint-Marcoux F, Knoop C, Debord J et al.. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.  Clin Pharmacokinet. 2005;  44 1317-1328
    CrossrefPubMedGoogle Scholar
  • 87 Knoop C, Vervier I, Thiry P et al.. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.  Transplantation. 2003;  76 683-688
    CrossrefPubMedGoogle Scholar
  • 88 Berge M, Guillemain R, Boussaud V et al.. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.  Transpl Infect Dis. 2009;  11 211-219
    CrossrefPubMedGoogle Scholar
  • 89 Cadena J, Levine D J, Angel L F et al.. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.  Am J Transplant. 2009;  9 2085-2091
    CrossrefPubMedGoogle Scholar
  • 90 Veith F J, Kamholz S L, Mollenkopf F P, Montefusco C M. Lung transplantation 1983.  Transplantation. 1983;  35 271-278
    PubMedGoogle Scholar
  • 91 Date H, Trulock E P, Arcidi J M, Sundaresan S, Cooper J D, Patterson G A. Improved airway healing after lung transplantation: an analysis of 348 bronchial anastomoses.  J Thorac Cardiovasc Surg. 1995;  110 1424-1432, discussion 1432–1433
    PubMedGoogle Scholar
  • 92 Weder W, Inci I, Korom S et al.. Airway complications after lung transplantation: risk factors, prevention and outcome.  Eur J Cardiothorac Surg. 2009;  35 293-298, discussion 298
    CrossrefPubMedGoogle Scholar
  • 93 Moreno P, Alvarez A, Algar F J et al.. Incidence, management and clinical outcomes of patients with airway complications following lung transplantation.  Eur J Cardiothorac Surg. 2008;  34 1198-1205
    CrossrefPubMedGoogle Scholar
  • 94 Vos R, Vanaudenaerde B M, Geudens N, Dupont L J, Van Raemdonck D E, Verleden G M. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?.  Eur Respir J. 2008;  31 1037-1045
    CrossrefPubMedGoogle Scholar
  • 95 Bonvillain R W, Valentine V G, Lombard G, LaPlace S, Dhillon G, Wang G. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.  J Heart Lung Transplant. 2007;  26 890-897
    CrossrefPubMedGoogle Scholar
  • 96 Gottlieb J, Mattner F, Weissbrodt H et al.. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.  Respir Med. 2009;  103 743-749
    CrossrefPubMedGoogle Scholar
  • 97 Sarahrudi K, Estenne M, Corris P et al.. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.  J Thorac Cardiovasc Surg. 2004;  127 1126-1132
    CrossrefPubMedGoogle Scholar
  • 98 Gerhardt S G, McDyer J F, Girgis R E, Conte J V, Yang S C, Orens J B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.  Am J Respir Crit Care Med. 2003;  168 121-125
    CrossrefPubMedGoogle Scholar
  • 99 Verleden G M, Dupont L J. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.  Transplantation. 2004;  77 1465-1467
    CrossrefPubMedGoogle Scholar
  • 100 Yates B, Murphy D M, Forrest I A et al.. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.  Am J Respir Crit Care Med. 2005;  172 772-775
    CrossrefPubMedGoogle Scholar
  • 101 Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.  Transplantation. 2008;  85 36-41
    CrossrefPubMedGoogle Scholar
  • 102 Mertens V, Blondeau K, Pauwels A et al.. Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients.  Dig Dis Sci. 2009;  54 972-979
    CrossrefPubMedGoogle Scholar
  • 103 Egan T M, Detterbeck F C, Mill M R et al.. Improved results of lung transplantation for patients with cystic fibrosis.  J Thorac Cardiovasc Surg. 1995;  109 224-234, discussion 234–235
    PubMedGoogle Scholar
  • 104 Williams T J, Patterson G A, McClean P A, Zamel N, Maurer J R. Maximal exercise testing in single and double lung transplant recipients.  Am Rev Respir Dis. 1992;  145 101-105
    CrossrefPubMedGoogle Scholar
  • 105 Levy R D, Ernst P, Levine S M et al.. Exercise performance after lung transplantation.  J Heart Lung Transplant. 1993;  12(1 Pt 1) 27-33
    PubMedGoogle Scholar
  • 106 Egan T M, Detterbeck F C, Mill M R et al.. Long term results of lung transplantation for cystic fibrosis.  Eur J Cardiothorac Surg. 2002;  22 602-609
    CrossrefPubMedGoogle Scholar
  • 107 Vermeulen K M, van der Bij W, Erasmus M E, Duiverman E J, Koëter G H, TenVergert E M. Improved quality of life after lung transplantation in individuals with cystic fibrosis.  Pediatr Pulmonol. 2004;  37 419-426
    CrossrefPubMedGoogle Scholar
  • 108 Choong C K, Meyers B F. Quality of life after lung transplantation.  Thorac Surg Clin. 2004;  14 385-407
    CrossrefPubMedGoogle Scholar
  • 109 Smeritschnig B, Jaksch P, Kocher A et al.. Quality of life after lung transplantation: a cross-sectional study.  J Heart Lung Transplant. 2005;  24 474-480
    CrossrefPubMedGoogle Scholar

Keith C MeyerM.D. M.S. 

Section of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health

K4/910 CSC, 600 Highland Ave., Madison, WI 53792-9988

Email: kcm@medicine.wisc.edu

      >